Evofem Biosciences, INC. 8-K Filing

Ticker: EVFM · Form: 8-K · Filed: Nov 26, 2025 · CIK: 1618835

Sentiment: neutral

Filing Stats: 1,216 words · 5 min read · ~4 pages · Grade level 12.2 · Accepted 2025-11-26 16:49:01

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. EVOFEM BIOSCIENCES, INC. Dated: November 26, 2025 By: /s/ Saundra Pelletier Saundra Pelletier Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing